SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-060034
Filing Date
2024-05-15
Accepted
2024-05-15 07:30:36
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sldb-20240331.htm   iXBRL 10-Q 1761900
2 EX-10.2 sldb-ex10_2.htm EX-10.2 324648
3 EX-31.1 sldb-ex31_1.htm EX-31.1 14629
4 EX-31.2 sldb-ex31_2.htm EX-31.2 14600
5 EX-32.1 sldb-ex32_1.htm EX-32.1 8504
6 EX-32.2 sldb-ex32_2.htm EX-32.2 8487
7 GRAPHIC img63628206_0.jpg GRAPHIC 17140
8 GRAPHIC img63628206_1.jpg GRAPHIC 17140
9 GRAPHIC img63628206_2.jpg GRAPHIC 17119
10 GRAPHIC img63628206_3.jpg GRAPHIC 17207
11 GRAPHIC img63628206_4.jpg GRAPHIC 17207
  Complete submission text file 0000950170-24-060034.txt   6796726

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sldb-20240331.xsd EX-101.SCH 1004079
77 EXTRACTED XBRL INSTANCE DOCUMENT sldb-20240331_htm.xml XML 798094
Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

IRS No.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38360 | Film No.: 24947154
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)